Literature DB >> 16254903

Beta-globin cluster haplotypes in normal individuals and beta(0)39-thalassemia carriers from Sardinia, Italy.

I Piras1, G Vona, A Falchi, V Latini, S Ristaldi, L Vacca, L Varesi, C M Calò.   

Abstract

Seven polymorphic sites in the beta-globin cluster in association with specific thalassemia mutations were analyzed in a sample from Sardinia, Italy. In order to verify previous works carried out on normal samples (beta(A)/beta(A)) and family studies on beta-thalassemia homozygotes individuals, the haplotype frequencies in both normal individuals (beta(A)/beta(A)) and beta(0)39-thalassemia carriers (beta(A)/beta0) were studied. In our work chromosomes carrying beta(0)39 mutation are characterized by a prevalence of haplotype II (- + + - + + +) (52%) relative to haplotype I (+- - - - + +) (29%), in contrast, among chromosomes with beta(A) the frequency of haplotype I is much greater than that of haplotype II. These data confirm what was found by other authors. Nevertheless, our results disagree with those of previous studies of Sardinians, both in frequencies values and in the numbers of haplotypes identified. Population analysis performed with samples carrying the beta-thalassemic mutation highlighted the peculiarity of Sardinians with respect to other Mediterranean populations. The Corsican population is most similar to the Sardinian population, confirming previous analyses performed with both classical markers and mitochondrial and genomic DNA. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16254903     DOI: 10.1002/ajhb.20442

Source DB:  PubMed          Journal:  Am J Hum Biol        ISSN: 1042-0533            Impact factor:   1.937


  4 in total

1.  Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassaemia mutation for the screening of correctors of stop-codon mutations.

Authors:  Francesca Salvatori; Vera Cantale; Giulia Breveglieri; Cristina Zuccato; Alessia Finotti; Nicoletta Bianchi; Monica Borgatti; Giordana Feriotto; Federica Destro; Alessandro Canella; Laura Breda; Stefano Rivella; Roberto Gambari
Journal:  Biotechnol Appl Biochem       Date:  2009-07-09       Impact factor: 2.431

2.  Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patients.

Authors:  Francesca Salvatori; Giulia Breveglieri; Cristina Zuccato; Alessia Finotti; Nicoletta Bianchi; Monica Borgatti; Giordana Feriotto; Federica Destro; Alessandro Canella; Eleonora Brognara; Ilaria Lampronti; Laura Breda; Stefano Rivella; Roberto Gambari
Journal:  Am J Hematol       Date:  2009-11       Impact factor: 10.047

3.  UPF1 silenced cellular model systems for screening of read-through agents active on β039 thalassemia point mutation.

Authors:  Francesca Salvatori; Mariangela Pappadà; Giulia Breveglieri; Elisabetta D'Aversa; Alessia Finotti; Ilaria Lampronti; Roberto Gambari; Monica Borgatti
Journal:  BMC Biotechnol       Date:  2018-05-15       Impact factor: 2.563

Review 4.  Screening Readthrough Compounds to Suppress Nonsense Mutations: Possible Application to β-Thalassemia.

Authors:  Monica Borgatti; Emiliano Altamura; Francesca Salvatori; Elisabetta D'Aversa; Nicola Altamura
Journal:  J Clin Med       Date:  2020-01-21       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.